Global Market for Cancer Immunology and Oncolytic Virology

1
Global Market for Cancer Immunology Oncolytic
Virology
2
Summary

• The global cancer immunotherapy market should
  reach 96.5 billion by 2021 from 73.0 billion in
  2016 at a compound annual growth rate (CAGR) of
  5.7, from 2016 to 2021.
• Introduction
• Goals and Objectives
• This report, PHM129B Cancer Immunology and
  Oncolytic Virology Technologies and Global
  Markets, provides an overview of the current and
  potential global market for cancer immunotherapy
  and oncolytic virology. This report provides
  information on most clinically significant types
  of cancers, with supportive information on
  historical incidence and mortality trends. It
  underlines the importance of more effective and
  personalized treatment options for these
  diseases. The objective of this report is to
  provide a comprehensive analysis of the current
  state and the future direction of cancer
  immunotherapy. Additionally, the report also
  provides information on the current developments
  in oncolytic virology and introduces the
  promising products in clinical trials.

3
(No Transcript)
4

• The conventional treatment paradigms, trends in
  each market segment, and clinical trials and
  outcomes are provided along with sales figures
  and forecasts for cancer immunotherapy and
  virotherapy products from 2015 through 2021. In
  this report, the critical evaluation of the
  products and markets is based on extensive
  primary and secondary research from industry
  sources. The evaluation takes into account
  regulatory policies as well as demographic and
  epidemiological factors that strongly influence
  the oncology market.

5
Reasons for Doing This Study

• The aim of this report is to provide detailed
  information on the new areas of cancer immunology
  and immunotherapy. Considering the shortcomings
  of the current treatment paradigms, immunotherapy
  has provided ground-breaking improvements in the
  treatment of different types of cancers. Growing
  clinical information stresses the importance of
  immunotherapy in cancer treatment. Immunotherapy
  addresses the need for more efficacious and
  flexible treatment strategies for managing the
  global burden of cancer. This report focuses on
  the new and latest types of treatment based on
  immunology. It also features oncolytic virology,
  a field that is still in its latency, with
  budding treatment options that promise clinical
  value for the treatment and management of cancer.

6
Intended Audience

• This report is a comprehensive study of the
  global market for immunotherapy and oncolytic
  virology. It includes statistical analysis of
  industry-oriented information on available and
  pipeline drugs discussion of technological
  trends and analysis of market landscape and
  structure in terms of market size, market
  segments, and geographical market regions. This
  report provides crucial information about market
  growth in cancer immunotherapy and oncolytic
  virology as indicated for the most common types
  of cancers. The in-detail analysis and forecasts
  of the market will be of interest to the
  pharmaceutical and biotechnology industries, as
  well as to healthcare providers and clinical and
  scientific research institutions. Additional
  audiences may include investment firms in this
  sector.

7
Scope of The Study

• The scope of this report covers current cancer
  immunotherapy markets for most common cancers.
  The market segments included in this report are
  therapeutic monoclonal antibodies (with special
  focus on checkpoint inhibitors), synthetic
  interleukins, interferons, and colony-stimulating
  factors small kinase inhibitors of
  cancer-related targets protective and
  therapeutic cancer vaccines and adoptive cell
  therapies. This report also covers treatments
  that are in development for late-stage and
  early-stage oncolytic viruses. Detailed
  epidemiological information, discussion of
  incidence and mortality trends, overview of
  regulatory landscapes, and analysis of market
  shares for leading products and companies are
  also included in this report.

8
Full Reports
Global Market for Cancer Immunology Oncolytic
Virology
Contact us atBharat Book Bureau Tel 91 22
27810772 / 27810773 Emailpoonam_at_bharatbook.com Ou
r Bloghttps//www.bharatbook.com/blog/ Twitterht
tps//twitter.com/researchbook Facebookhttps//ww
w.facebook.com/BharatBook3B LinkedInhttp//www.li
nkedin.com/company/bharat-book-bureau
9
THANK YOU